Haier Biomedical Showcases Innovative Blood Management and Cold Storage Solutions at AABB and ISPE 2026

Haier Biomedical at AABB and ISPE 2026



Haier Biomedical made significant waves during the AABB annual meeting and the ISPE Expo 2026 held in Atlanta and National Harbor, Maryland, respectively, from October 17 to 20, 2026. The company showcased advanced solutions for blood management and pharmaceutical cold storage, exemplifying its commitment to enhancing healthcare through technological innovations.

Expertise in Blood Management


Haier Biomedical presented its integrated blood management solutions, aimed at supporting medical professionals in plasma collection, blood storage, and transport. The company's plasma separator streamlines workflows by offering guided setup, automated testing, and adaptive control for efficient plasma collection. Further, electronic records enhance documentation and traceability, crucially supporting blood banks in maintaining stable storage conditions even with regular access.

The blood management solutions also feature cooling technologies that ensure reliable monitoring of blood products. With temperature alerts and advanced monitoring functions, Haier Biomedical ensures the integrity of blood products throughout the entire chain, including transport between facilities.

Innovative Cold Storage Solutions


At the ISPE conference, Haier Biomedical introduced solutions tailored to the interconnected demands of pharmaceutical laboratories, focusing on sample protection, energy efficiency, and reliable storage documentation. Their ultra-low temperature freezer employs hydrocarbon refrigerants for precise temperature control combined with energy-saving technologies, earning an ENERGY STAR certification, which confirms its efficacy in energy efficiency.

The devices come equipped with temperature alarms and easily accessible historical data, allowing lab staff to monitor storage conditions regularly. This not only keeps documentation up-to-date but also prepares them for inspections, ensuring compliance with regulatory standards.

Commitment to Standards and Collaboration


Beyond showcasing their cutting-edge equipment, Haier Biomedical emphasized their proactive role in setting international standards. Recently, they took the lead in proposing a project to the International Electrotechnical Commission (IEC) to develop the first global standard for medical (semi-)automatic cooling and freezing systems. This initiative aims to establish unified performance criteria and testing methodologies, making it easier for manufacturers to evaluate product designs and for customers to make informed comparisons.

Haier Biomedical remains committed to combining technological innovation, local service, and international collaboration to better support clients worldwide. Their ongoing partnerships are designed to help life sciences and healthcare institutions operate more reliably, efficiently, and sustainably.

About Haier Biomedical


Founded in 2005 under the Haier Group umbrella, Haier Biomedical provides equipment and digital solutions for the life sciences and healthcare sectors across more than 160 countries and regions. According to Euromonitor International, based on 2025 sales figures, Haier Biomedical ranks first among Chinese-owned brands in terms of global sales in laboratory equipment for life sciences, both overall and outside of China. The company has established long-term partnerships with approximately 80 international organizations, including the World Health Organization and UNICEF. For more information, visit Haier Biomedical.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.